Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Affiliations

¹ Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
² Section of Pediatric Neurology, Department of Pediatrics, University of Chicago, Chicago, IL.
³ Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.
⁴ Division of Neurogenetics and Neurodevelopmental Pediatrics, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC.

Arthur Lenahan et al. Genet Med Open. 2023.

. 2023 Sep 9;1(1):100832.

doi: 10.1016/j.gimo.2023.100832. eCollection 2023.

¹ Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
² Section of Pediatric Neurology, Department of Pediatrics, University of Chicago, Chicago, IL.
³ Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.
⁴ Division of Neurogenetics and Neurodevelopmental Pediatrics, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC.

No abstract available

Keywords: Friedreich ataxia; Neuromuscular medicine; Omaveloxolone; Orphan drug; Precision medicine.

Conflict of interest statement

The authors declare no conflicts of interest.

1. Bidichandani S.I., Delatycki M.B. In: GeneReviews. Adam M.P., Mirzaa G.M., Pagon R.A., editors. University of Washington; Seattle: 2017. Friedreich ataxia; pp. 1993–2023. December 18, 1998. Last update June 1, 2017. - PubMed
1. Paupe V., Dassa E.P., Goncalves S., et al. Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS ONE. 2009;4(1) doi: 10.1371/journal.pone.0004253. - DOI - PMC - PubMed
1. Corben L.A., Collins V., Milne S., et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. Orphanet J Rare Dis. 2022;17(1):415. doi: 10.1186/s13023-022-02568-3. - DOI - PMC - PubMed
1. Jain P., Badgujar L., Spoorendonk J., Buesch K. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review. Ther Adv Rare Dis. 2022;3 doi: 10.1177/26330040221139872. - DOI - PMC - PubMed
1. D’Oria V., Petrini S., Travaglini L., et al. Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons. Int J Mol Sci. 2013;14(4):7853–7865. doi: 10.3390/ijms14047853. - DOI - PMC - PubMed